Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Allegra S, De Francia S, Turco F, Bertaggia I, Chiara F, Armando T, Storto S, Mussa MV (2023) Phytotherapy and drugs: can their interactions increase side effects in cancer patients? J Xenobiotic 13:75–89. https://doi.org/10.3390/jox13010007
2. WHO (2007) World Health Organization guidelines for assessing quality of herbal medicines with reference to contaminants and residues. World Health Organization.
3. EPA (1993). Provisional guidance for qualitative risk assessment of polycyclic aromatic hydrocarbons Available at: http://EPA/600/R-93/089. Accessed14 Dec 2020
4. Krajian H, Odeh A (2013) Polycyclic aromatic hydrocarbons in medicinal plants from Syria. Toxicol Environ Chem 95:942–953
5. Patel AB, Shaikh S, Jain KR, Desai C, Madamwar D (2020) Polycyclic aromatic hydrocarbons: sources, toxicity, and remediation approaches. Front Microbiol 11:562813. https://doi.org/10.3389/fmicb.2020.562813